Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Search publicationsResearch updates
Browse dated psilocybin research updates, separate publication dates from indexing dates, explore monthly literature and follow confirmed research alerts.
Free access · No subscription for research tools or data exports
Observed research changes
Changes are recorded when registry data are refreshed. The initial snapshot is a baseline, not historical news. A registry-added result reference may point to an older publication; its observation date is not the paper's publication date.
Registry status changes · NCT06001749Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer · observed Oct 28, 2026 02:24 UTCRecruitment status changed to recruiting · NCT07405606Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial · observed Oct 27, 2026 02:22 UTCRecruitment status changed to recruiting · NCT07391332Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05554094Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial · observed Oct 17, 2026 01:22 UTCRegistry status changes · NCT05224336Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain · observed Oct 12, 2026 07:04 UTC
Opt in to research-change email alerts. Journal and citation filters apply to publications; use keyword, sponsor/author and topic filters for registry changes.
Monthly literature view
126 records have publication dates within this month. Issue dates may be assigned ahead of online availability. Date-added activity and publication-date activity describe different events.
Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trial2026-10-29 · medRxiv · PREPRINT (not peer reviewed)Multi-scale effects of single-dose psilocybin in the macaque brain2026-10-29 · Europe PMC · PREPRINT (not peer reviewed)Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease2026-10-29 · ClinicalTrials.gov · CLINICAL TRIALA Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.2026-10-29 · ClinicalTrials.gov · CLINICAL TRIALA Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression2026-10-29 · ClinicalTrials.gov · CLINICAL TRIALAn Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder2026-10-29 · ClinicalTrials.gov · CLINICAL TRIALQuantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A Receptor2026-10-28 · Europe PMC · PREPRINT (not peer reviewed)Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic study2026-10-28 · Crossref · PublishedHigh-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepis2026-10-28 · Crossref · PublishedPsychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethics2026-10-27 · OpenAlex · PublishedPsychedelics and psychosis: A systematic review of recent-era studies (1984-2025).2026-10-27 · Europe PMC · PublishedMagic pathways: the genes and enzymes of psilocybin biosynthesis.2026-10-27 · Europe PMC · PublishedFeasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer2026-10-27 · ClinicalTrials.gov · CLINICAL TRIALSafety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among Veterans2026-10-26 · ClinicalTrials.gov · CLINICAL TRIALSubstantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision Psychiatry2026-10-26 · Crossref · PublishedSingle Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.2026-10-26 · Europe PMC · PublishedSex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.2026-10-26 · Europe PMC · PublishedPsilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial2026-10-26 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism2026-10-26 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes2026-10-26 · ClinicalTrials.gov · CLINICAL TRIALDirect Quantitation of Psilocybin and Psilocin by 1H and 31P qNMR in Wild Psilocybe from Greece2026-10-24 · Europe PMC · PublishedPreparing the body for psilocybin therapy: receptive and generative interoception in cancer patients2026-10-24 · Europe PMC · PublishedPsilocybin and Clinical Depression2026-10-23 · OpenAlex · PublishedSustained antidepressant-like effects of psychedelics through 5-HT2AR-β-arrestin signaling.2026-10-23 · Europe PMC · PublishedA Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder2026-10-23 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder2026-10-23 · ClinicalTrials.gov · CLINICAL TRIALA Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans2026-10-23 · ClinicalTrials.gov · CLINICAL TRIALMikrodosiertes Psilocybin im palliativmedizinischen Kontext2026-10-21 · Crossref · PublishedPsilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.2026-10-21 · Europe PMC · PublishedA Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)2026-10-21 · ClinicalTrials.gov · CLINICAL TRIALTreatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial2026-10-21 · ClinicalTrials.gov · CLINICAL TRIALHow Psilocybin Alters Consciousness2026-10-20 · OpenAlex · PublishedClinical Evidence on Psilocybin and Its Representation in Media Reporting2026-10-20 · Crossref · PublishedDirect Quantitation of Psilocybin and Psilocin by H and P qNMR in Wild from Greece.2026-10-20 · PubMed · PublishedA Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety2026-10-20 · ClinicalTrials.gov · CLINICAL TRIALActivating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin2026-10-20 · ClinicalTrials.gov · CLINICAL TRIALMicrodosing Psychedelics to Improve Mood2026-10-20 · ClinicalTrials.gov · CLINICAL TRIALPsilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.2026-10-19 · Europe PMC · PublishedMichael Pollan’s Psychedelic Renaissance: Settler Colonial Time and the De-Indigenization of Mazatec Mushroom Medicine2026-10-19 · OpenAlex · PublishedBiosynthesis of gold nanoparticles using Psilocybe cubensis extracts and their biostimulatory evaluation in Neuro2a cells2026-10-19 · OpenAlex · PublishedPsilocybin in Treatment-Resistant Depression: Weighing Rapid Antidepressant Effects Against Uncertain Durability2026-10-19 · Crossref · PublishedInvestigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice.2026-10-19 · Europe PMC · PublishedPsychoplastogens to Reduce Persistent Cognitive Symptoms for Traumatic Brain Injury as a Chronic Condition.2026-10-19 · Europe PMC · PublishedImaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)2026-10-19 · ClinicalTrials.gov · CLINICAL TRIALA Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)2026-10-19 · ClinicalTrials.gov · CLINICAL TRIALFrom Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha2026-10-18 · OpenAlex · PublishedSerotonin 1B receptors expressed on forebrain excitatory neurons mediate the post-acute anxiolytic response to psilocybin in mice.2026-10-17 · Europe PMC · PublishedAdverse outcomes of psychedelics self-reported: Survey2026-10-16 · OpenAlex · PublishedFrench psychiatric caregivers' perceptions of psychedelics: A national survey.2026-10-16 · Europe PMC · PublishedThe Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin2026-10-16 · ClinicalTrials.gov · CLINICAL TRIAL
Recently indexed records
These entries are ordered by when they entered this index, not when the underlying study was conducted or published. A newly indexed old paper is not a new finding.
Quantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A ReceptorIndexed 2026-10-30 02:20:18 · publication date 2026-10-28 · PREPRINT (not peer reviewed)Psilocybin, cognitive stability and drinking reduction in co-occurring alcohol use disorder and depression: a pilot secondary analysis of a randomized, placebo-controlled trialIndexed 2026-10-30 02:20:18 · publication date 2026-10-29 · PREPRINT (not peer reviewed)Multi-scale effects of single-dose psilocybin in the macaque brainIndexed 2026-10-30 02:20:18 · publication date 2026-10-29 · PREPRINT (not peer reviewed)Psychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethicsIndexed 2026-10-29 02:20:17 · publication date 2026-10-27 · PublishedConnectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic studyIndexed 2026-10-29 02:20:13 · publication date 2026-10-28 · PublishedHigh-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepisIndexed 2026-10-29 02:20:12 · publication date 2026-10-28 · PublishedPsychedelics and psychosis: A systematic review of recent-era studies (1984-2025).Indexed 2026-10-28 02:20:05 · publication date 2026-10-27 · PublishedMagic pathways: the genes and enzymes of psilocybin biosynthesis.Indexed 2026-10-28 02:20:05 · publication date 2026-10-27 · PublishedSafety, Efficacy, and Mechanisms of Psilocybin-assisted Acceptance and Commitment Therapy (PACT) in Treating Major Depressive Disorder (MDD) Among VeteransIndexed 2026-10-27 02:22:54 · publication date 2026-10-26 · CLINICAL TRIALSubstantial Treatment-Seeking Interest, Narrow Eligibility: Diagnostic Heterogeneity and External Validity in the PRIDE Psilocybin Trial-Relevance to Precision PsychiatryIndexed 2026-10-27 02:20:16 · publication date 2026-10-26 · PublishedSingle Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.Indexed 2026-10-27 02:20:04 · publication date 2026-10-26 · PublishedSex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.Indexed 2026-10-27 02:20:04 · publication date 2026-10-26 · PublishedDirect Quantitation of Psilocybin and Psilocin by 1H and 31P qNMR in Wild Psilocybe from GreeceIndexed 2026-10-26 02:20:18 · publication date 2026-10-24 · PublishedPsilocybin and Clinical DepressionIndexed 2026-10-25 02:20:27 · publication date 2026-10-23 · PublishedSustained antidepressant-like effects of psychedelics through 5-HT2AR-β-arrestin signaling.Indexed 2026-10-25 02:20:05 · publication date 2026-10-23 · Published